American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...
Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...
Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...
India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...
Benchmark indices closed higher on Monday, boosted by pharmaceutical and financial stocks, with Sensex up 0.46% and Nifty 0.5 ...
The Trump administration's decision to pause U.S. foreign aid has "substantially disrupted" supply of HIV treatments in eight ...
In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...
Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...
Benchmark indices end mixed as BSE Sensex closes slightly lower, NSE Nifty edges up; selective buying boosts recovery amid ...
Domestic stock indices saw minor gains on Monday, buoyed by receding fears of a US government shutdown and anticipation of the US Federal Reserve's upcoming policy review. The Nifty closed just above ...
Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results